GAMMA-AMINOBUTYRIC ACID-OPIOID INTERACTIONS IN THE REGULATION OF GONADOTROPIN-SECRETION IN THE IMMATURE FEMALE RAT

被引:27
作者
BRANN, DW [1 ]
ZAMORANO, PL [1 ]
PUTNAMROBERTS, CD [1 ]
MAHESH, VB [1 ]
机构
[1] MED COLL GEORGIA,DEPT PHYSIOL & ENDOCRINOL,AUGUSTA,GA 30912
关键词
GABA; OPIOIDS; LH; GONADOTROPINS; NALOXONE;
D O I
10.1159/000126281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previous studies in the male rat have demonstrated that GABA acting via GABA(B) receptors can abolish naloxone-induced LH secretion. The purpose of the present study was to determine if an analogous situation exists in the female rat. Naloxone administered to ovariectomized immature rats had no effect on LH release. In contrast, naloxone potently stimulated LH release in estrogen-primed ovariectomized immature rats. Elevation of endogenous brain levels of GABA by administering amino-oxyacetic acid, an inhibitor of GABA catabolism, prevented the naloxone-stimulated release of LH. This effect appeared to be both GABA(A) and GABA(B) receptor mediated, since exogenous administration of either muscimol (GABA(A) agonist) or baclofen (GABA(B) agonist) prevented the naloxone-induced release of LH. Neither GABA agonist had any effect on LHRH-stimulated LH release in vivo, suggesting that their effect was specific and achieved at the level of the CNS. In contrast to its inhibitory effect on naloxone-stimulated LH and FSH release, muscimol increased basal LH and FSH release in vivo and from hemipituitaries incubated in vitro, while having no effect on LHRH release from mediobasal hypothalamic and preoptic area fragments in vitro. Thus, under conditions of basal LH release, activation of GABA(A) receptors in the anterior pituitary can actually lead to enhanced LH secretion. Finally, naloxone-stimulated LH release was found to be inhibited by the alpha1- and alpha2-adrenergic blockers, prazosin and yohimbine, suggesting that naloxone-stimulated LH release is mediated via catecholamine neurotransmission involving alpha1- and alpha2-adrenergic receptor activation. These studies provide insights into the complex effects of GABA on basal and elevated LH secretion in the female rat, and they demonstrate a sex difference in the ability of GABA(A) and GABA(B) receptor activation to modulate naloxone-stimulated LH secretion.
引用
收藏
页码:445 / 452
页数:8
相关论文
共 45 条
[1]   EVIDENCE FOR GAMMA-AMINOBUTYRIC-ACID MODULATION OF OVARIAN HORMONAL EFFECTS ON LUTEINIZING-HORMONE SECRETION AND HYPOTHALAMIC CATECHOLAMINE ACTIVITY IN THE FEMALE RAT [J].
ADLER, BA ;
CROWLEY, WR .
ENDOCRINOLOGY, 1986, 118 (01) :91-97
[2]   MODULATION OF LUTEINIZING-HORMONE RELEASE AND CATECHOLAMINE ACTIVITY BY OPIATES IN THE FEMALE RAT [J].
ADLER, BA ;
CROWLEY, WR .
NEUROENDOCRINOLOGY, 1984, 38 (03) :248-253
[3]   OPIATERGIC CONTROL OF LH-SECRETION IS ELIMINATED BY GONADECTOMY [J].
BHANOT, R ;
WILKINSON, M .
ENDOCRINOLOGY, 1983, 112 (01) :399-401
[4]   MONO-AMINERGIC ANTAGONISTS WHICH BLOCK NALOXONE-INDUCED RELEASE OF LUTEINIZING-HORMONE BIND SELECTIVELY TO HYPOTHALAMIC OPIATE RECEPTORS [J].
BLANK, MS ;
DIEZ, JA ;
ROBERTS, DL .
BRAIN RESEARCH, 1983, 279 (1-2) :153-158
[5]   ANTAGONIST OF GONADOTROPIN-RELEASING HORMONE BLOCKS NALOXONE-INDUCED ELEVATIONS IN SERUM LUTEINIZING-HORMONE [J].
BLANK, MS ;
ROBERTS, DL .
NEUROENDOCRINOLOGY, 1982, 35 (05) :309-312
[6]  
BOLTON AE, 1977, RADIOCHEMICAL CTR RE, V18, P45
[7]   ENDOGENOUS EXCITATORY AMINO-ACID INVOLVEMENT IN THE PREOVULATORY AND STEROID-INDUCED SURGE OF GONADOTROPINS IN THE FEMALE RAT [J].
BRANN, DW ;
MAHESH, VB .
ENDOCRINOLOGY, 1991, 128 (03) :1541-1547
[8]   DETAILED EXAMINATION OF THE MECHANISM AND SITE OF ACTION OF PROGESTERONE AND CORTICOSTEROIDS IN THE REGULATION OF GONADOTROPIN-SECRETION - HYPOTHALAMIC GONADOTROPIN-RELEASING-HORMONE AND CATECHOLAMINE INVOLVEMENT [J].
BRANN, DW ;
MAHESH, VB .
BIOLOGY OF REPRODUCTION, 1991, 44 (06) :1005-1015
[9]  
BRANN DW, 1991, FRONT NEUROENDOCRIN, V12, P154
[10]   EFFECT OF AMINOOXYACETIC ACID (AOAA) ON GABA LEVELS IN SOME PARTS OF THE RAT-BRAIN [J].
CARMONA, E ;
GOMES, C ;
TROLIN, G .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 312 (01) :51-55